Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX®
Clinical trial NCT04281745 · UNKNOWN
Trial details
- NCT number
- NCT04281745
- Sponsor
- Medy-Tox
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-17
- Primary completion
- 2020-06-17
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.